0001127602-20-030926.txt : 20201208
0001127602-20-030926.hdr.sgml : 20201208
20201208193242
ACCESSION NUMBER: 0001127602-20-030926
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201204
FILED AS OF DATE: 20201208
DATE AS OF CHANGE: 20201208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Perry Nicole D
CENTRAL INDEX KEY: 0001657874
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 201376541
MAIL ADDRESS:
STREET 1: 6400 WESTWIND WAY
STREET 2: SUITE A
CITY: CRESTWOOD
STATE: KY
ZIP: 40014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-977-5700
MAIL ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-12-04
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001657874
Perry Nicole D
C/O APELLIS PHARMACEUTICALS, INC.
100 FIFTH AVENUE, 3RD FLOOR
WALTHAM
MA
02451
1
Vice President - Accounting
Common Stock
2020-12-04
4
M
0
18000
3.76
A
18000
D
Common Stock
2020-12-04
4
S
0
18000
50.00
D
0
D
Stock Option (Right to Buy)
3.76
2020-12-04
4
M
0
18000
0
D
2025-07-31
Common Stock
18000
17161
D
This option was granted on July 31, 2015 and is fully vested.
This is a scheduled exercise from a 10B5-1 trading plan.
/s/ David Watson, attorney-in-fact for Nicole Perry
2020-12-08